Press Releases on November 12, 2019 - EIN Presswire - Press Release Distribution Service

Published on November 12, 2019 - 12:00 GMT

Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation SNF472 significantly reduced progression of cardiovascular calcification in patients with end stage kidney disease (ESKD) receiving hemodialysis SNF472 treated patients …

Distribution channels: Media, Advertising & PR

Published on November 12, 2019 - 12:00 GMT

ZINFI Platform Named a Leader in G2’s Fall 2019 Report on Partner Management Software

Reviews from G2 user community as well as data aggregated from online sources and social networks earn ZINFI a spot in the G2 “Leaders” quadrant; platform earns #1 ranking in satisfaction and a Top 4 ranking in usability PLEASANTON, Calif., Nov. 12, 2019 ( …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 12, 2019 - 12:00 GMT

G1 Therapeutics to Present at Stifel Healthcare Conference on November 19, 2019

RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the Stifel …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 12, 2019 - 12:00 GMT

PubMatic’s Q3 Research Highlighted by Ongoing Evolution in Mobile Advertising

REDWOOD CITY, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Premium digital advertising technology company, PubMatic, today released the findings of its third Quarterly Mobile Index (QMI), highlighting three key Q3 2019 trends. The report provides both …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on November 12, 2019 - 12:00 GMT

InspireMD Announces Third Quarter 2019 Financial Results

Strong revenue driven by record orders of CGuard™ EPS Management to host investor conference call today, November 12, at 8:30am ET TEL AVIV, Israel, Nov. 12, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today reported financial results for the third quarter ended September 30, 2019 …

Distribution channels: Business & Economy, Technology ...

Published on November 12, 2019 - 12:00 GMT

TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced financial results …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell ...

The companies will continue to collaborate to discover and develop the next generation of engineered alpha-beta T cells Editas Medicine to receive a $70 million payment and may be eligible for future milestone and royalty payments CAMBRIDGE, Mass., Nov. 12 …

Distribution channels: Companies, Media, Advertising & PR ...

Published on November 12, 2019 - 12:00 GMT

Synalloy Reports Third Quarter 2019 Results

RICHMOND, Va., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Synalloy Corporation (Nasdaq: SYNL), today announced net sales for the third quarter of 2019 of $73.6 million. This represents a decrease of $4.2 million or 5.3% when compared to net sales for the third …

Distribution channels: Business & Economy, Energy Industry ...

Published on November 12, 2019 - 12:00 GMT

Neovasc Reducer™ Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany

VANCOUVER and MAINZ, Germany, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 12, 2019 - 12:00 GMT

Ferrellgas, L.P., Reaches Agreement With Lender Regarding Alleged Defaults

LIBERTY, Mo., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Ferrellgas, L.P., the operating partnership of Ferrellgas Partners, L.P. (NYSE:FGP) (“Ferrellgas”) announced today that it reached an agreement with TPG Specialty Lending, Inc., the administrative agent (“TPG …

Distribution channels: Energy Industry, Media, Advertising & PR ...

Published on November 12, 2019 - 12:00 GMT

Covetrus Announces Financial Results for Third Quarter of 2019

GAAP net sales of $1.0 billion, an increase of 10% year-over-year; non-GAAP pro forma organic net sales increased 5% year-over-year Net loss of $906 million, including a non-cash goodwill impairment charge of $939 million; non-GAAP adjusted net income of …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

MustGrow to Commence Work on Disease Threatening Global Banana Supply: Fusarium wilt Tropical Race 4

National state of emergency declared in Colombia. New soil-borne Fusarium pathogen is threatening the global supply of bananas. Effective eradication is currently not possible, with Fusarium wilt TR4 remaining viable for decades in the soil. MustGrow …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2019 - 12:00 GMT

Synchronoss Advanced Messaging Technology Will Help Power a Fully Interoperable, Rich Messaging Application for CCMI New Joint ...

BRIDGEWATER, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (NASDAQ:SNCR), a global leader and innovator of cloud, messaging, digital and IoT products, today announced that it is working with a new joint venture formed by the four …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

Avadel Pharmaceuticals Reports Third Quarter 2019 Financial Results and Raises Revenue Guidance for FY2019

Enrollment currently at 200 patients for the pivotal REST-ON Phase 3 study (97.5% complete); the Company currently expects to complete patient enrollment by end of 2019, with data readout expected in Q2 2020 Revenue of $48.2 million for first nine months …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

US Army Chooses Ryan Aerospace (Australia) to Supply 31 Helicopter Simulators Featuring Motion by D-BOX

MONTREAL, Nov. 12, 2019 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX”) (TSX:DBO), a pioneer and innovative leader in cutting-edge motion-cueing systems, congratulates Ryan Aerospace Australia for signing a contract to supply 31 Helimod Mark III …

Distribution channels:

Published on November 12, 2019 - 12:00 GMT

ENGlobal Reports Results for Third Quarter 2019

Houston, Nov. 12, 2019 (GLOBE NEWSWIRE) -- ENGlobal (NASDAQ:ENG), a leading provider of engineered modular solutions, today reported that for the third quarter ended September 28, 2019, the company had a net loss of $716,000, or $(.03) per diluted share, …

Distribution channels: Technology

Published on November 12, 2019 - 12:00 GMT

Marathon Gold Recognized by CIM Newfoundland and Labrador Branch as Developer of the Year

TORONTO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Marathon Gold Corporation (“Marathon” or the “Company”) (TSX: MOZ) is pleased to announce that at the recent Mineral Resource Review, the annual conference of the Canadian Institute of Mining-Newfoundland and …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on November 12, 2019 - 12:00 GMT

Kezar Announces Promising New Data with KZR-616 at the American College of Rheumatology Annual Meeting

Step-up dose titration lowered GI side effects while maintaining clinical activity Majority of patients completing 13 weeks of treatment demonstrated significant improvement on at least 2 measures of disease activity Conference Call and Webcast today at 8: …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on November 12, 2019 - 12:00 GMT

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year ...

NEWTOWN, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30 …

Distribution channels: